Connection

Raymond DuBois to Anti-Inflammatory Agents, Non-Steroidal

Back to Details
This is a "connection" page, showing publications Raymond DuBois has written about Anti-Inflammatory Agents, Non-Steroidal.
Raymond DuBois
Connection Strength
2.671
Anti-Inflammatory Agents, Non-Steroidal
  1. The role of anti-inflammatory drugs in colorectal cancer. Annu Rev Med. 2013; 64:131-44.
    View in: PubMed
    Score: 0.356
  2. NSAIDs and cancer prevention: targets downstream of COX-2. Annu Rev Med. 2007; 58:239-52.
    View in: PubMed
    Score: 0.239
  3. NSAIDs and prostate cancer risk. Cancer J. 2006 Mar-Apr; 12(2):108-9.
    View in: PubMed
    Score: 0.225
  4. Mechanisms for the prevention of gastrointestinal cancer: the role of prostaglandin E2. Oncology. 2005; 69 Suppl 1:28-32.
    View in: PubMed
    Score: 0.219
  5. Aspirin and breast cancer prevention: the estrogen connection. JAMA. 2004 May 26; 291(20):2488-9.
    View in: PubMed
    Score: 0.200
  6. COX-2 inhibition and colorectal cancer. Semin Oncol. 2004 Apr; 31(2 Suppl 7):12-21.
    View in: PubMed
    Score: 0.197
  7. New agents for cancer prevention. J Natl Cancer Inst. 2002 Dec 04; 94(23):1732-3.
    View in: PubMed
    Score: 0.180
  8. The COX-2-PGE2 Pathway Promotes Tumor Evasion in Colorectal Adenomas. Cancer Prev Res (Phila). 2022 05 03; 15(5):285-296.
    View in: PubMed
    Score: 0.173
  9. Cyclooxygenase-2 inhibitor therapy for the prevention of esophageal adenocarcinoma in Barrett's esophagus. J Natl Cancer Inst. 2002 Mar 20; 94(6):406-7.
    View in: PubMed
    Score: 0.172
  10. Cyclooxygenase-2: a therapeutic target. Annu Rev Med. 2002; 53:35-57.
    View in: PubMed
    Score: 0.169
  11. New, long-term insights from the Adenoma Prevention with Celecoxib Trial on a promising but troubled class of drugs. Cancer Prev Res (Phila). 2009 Apr; 2(4):285-7.
    View in: PubMed
    Score: 0.070
  12. Targeting cyclooxygenase-2 and the epidermal growth factor receptor for the prevention and treatment of intestinal cancer. Cancer Res. 2007 Oct 01; 67(19):9380-8.
    View in: PubMed
    Score: 0.063
  13. COX-2: a molecular target for colorectal cancer prevention. J Clin Oncol. 2005 Apr 20; 23(12):2840-55.
    View in: PubMed
    Score: 0.053
  14. Outcome of upper gastro-intestinal bleeding and use of ibuprofen versus paracetamol. Pharm World Sci. 2004 Dec; 26(6):319-23.
    View in: PubMed
    Score: 0.052
  15. Cyclooxygenase-2 in lung carcinogenesis and chemoprevention: Roger S. Mitchell lecture. Chest. 2004 May; 125(5 Suppl):134S-40S.
    View in: PubMed
    Score: 0.050
  16. Cyclooxygenase-2 and gastrointestinal cancer. Cancer J. 2004 May-Jun; 10(3):145-52.
    View in: PubMed
    Score: 0.050
  17. Will an aspirin a day keep the endoscope away? Gastroenterology. 2003 Aug; 125(2):612-4.
    View in: PubMed
    Score: 0.047
  18. Cyclooxygenase-2 and colorectal cancer. Prog Exp Tumor Res. 2003; 37:124-37.
    View in: PubMed
    Score: 0.045
  19. Controversies in COX-2 selective inhibition. J Rheumatol. 2002 Jul; 29(7):1501-10.
    View in: PubMed
    Score: 0.044
  20. COX-2: a target for colon cancer prevention. Annu Rev Pharmacol Toxicol. 2002; 42:55-80.
    View in: PubMed
    Score: 0.042
  21. Extracellular signal-regulated kinase is a target of cyclooxygenase-1-peroxisome proliferator-activated receptor-delta signaling in epithelial ovarian cancer. Cancer Res. 2007 Jun 01; 67(11):5285-92.
    View in: PubMed
    Score: 0.015
  22. New avenues for the prevention of colorectal cancer: targeting cyclo-oxygenase-2 activity. Best Pract Res Clin Gastroenterol. 2002 Dec; 16(6):945-56.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.